Roundup Settlement Eligibility: What the $7.25 Billion Deal Means for You
Roundup Settlement Eligibility: What the $7.25 Billion Deal Means for You
If you or someone you love sprayed Roundup for years — on a farm, a golf course, a school campus, or your own backyard — and was later diagnosed with non-Hodgkin lymphoma, you have probably heard that a massive settlement is on the table. Understandably, you want to know one thing: does it apply to you?
Monsanto, now owned by Bayer, has proposed a $7.25 billion nationwide settlement to resolve claims that long-term exposure to Roundup’s active ingredient, glyphosate, causes non-Hodgkin lymphoma. Because Roundup settlement eligibility depends on specific facts about your diagnosis and exposure history, the honest answer is “it depends” — but here is what the deal covers, who it is meant to help, and what to do next.
What the Proposed Roundup Settlement Covers
Monsanto and plaintiffs’ counsel have asked a Missouri circuit court judge in St. Louis to approve a nationwide class settlement covering both existing and future non-Hodgkin lymphoma claims tied to Roundup exposure. In short, the fund is designed to compensate people who were diagnosed before the settlement and people who develop the disease later, after years of prior exposure.
Under the current proposal, individual payouts vary widely based on the severity of the diagnosis, age at exposure, and other factors. Reported average payments range from roughly $6,000 to $165,000 per qualifying diagnosis, with some claims reaching close to $198,000 after adjustments. The total fund would be paid out over 17 to 21 years, with about $1 billion front-loaded in the first year.
Because this is a proposed settlement, it still needs court approval before it becomes final. A fairness hearing was scheduled in St. Louis for August 19, 2026, and as of this writing, final approval was still pending. In short, the settlement is real and moving forward, but it is not yet a done deal — which is exactly why timing matters for anyone who thinks they may qualify.
Who May Qualify for Roundup Settlement Eligibility
Every case turns on its own facts, and only a licensed attorney reviewing your records can tell you where you stand. That said, people who are typically considered for this kind of fund generally share a few things in common:
- A confirmed diagnosis of non-Hodgkin lymphoma (or certain related blood cancers), rather than a general cancer diagnosis
- A documented history of regular, repeated Roundup or glyphosate-based herbicide use — for example, as a farmworker, groundskeeper, landscaper, nursery employee, or frequent home or garden user
- Exposure that occurred before the settlement’s cutoff dates, or, for future claims, a new diagnosis that develops after years of past exposure
- No prior settlement, verdict, or release already covering the same claim
If you already have a Roundup lawsuit pending, you may have a separate set of choices — including whether to participate in the class settlement or pursue your case individually. Those decisions carry real trade-offs, so they are worth discussing with an attorney before any deadline passes.
The Science Behind the Roundup Claims
Roundup litigation exists because of a genuine, ongoing dispute over how dangerous glyphosate really is. The International Agency for Research on Cancer, the World Health Organization’s cancer research arm, classified glyphosate as a “probable human carcinogen” in 2015 based on its review of the available studies. The Environmental Protection Agency has reached a different conclusion in its own regulatory reviews, finding that glyphosate is unlikely to pose a cancer risk to humans when used according to the label. Readers can review EPA’s own assessment of glyphosate directly on the agency’s website.
That scientific disagreement is precisely what juries and now settlement negotiators have had to work through case by case. As of August 2026, Monsanto had reportedly resolved nearly 100,000 Roundup lawsuits nationwide, paying out roughly $11 billion combined through individual verdicts and block settlements. Tens of thousands of additional cases remain active, most in state courts around the country, with several thousand more consolidated in the federal multidistrict litigation in California.
What to Do If You Were Exposed
If you have a non-Hodgkin lymphoma diagnosis and a history of Roundup or glyphosate exposure, a few practical steps can protect your options while the settlement moves through court:
- Gather your medical records. Pathology reports, oncology notes, and treatment dates all matter for establishing your diagnosis.
- Document your exposure history. Job records, pay stubs, purchase receipts, or even a written timeline of when and how often you used Roundup can support a claim.
- Do not sign anything from the settlement administrator without legal review. Settlement paperwork can affect your rights permanently.
- Talk to an attorney before any filing or opt-out deadline. Deadlines in mass settlements move quickly, and missing one can close off options you did not know you had.
How Trial Lawyers United Can Help
Trial Lawyers United represents individuals nationwide in mass tort litigation, including through our national Roundup lawsuit team. Our attorneys investigate each client’s exposure history, evaluate whether a proposed settlement fairly values a specific diagnosis, and, where it makes sense, prepare to litigate a case individually rather than accept a discounted resolution. We prepare every case as if it is going to trial — a posture that shapes how seriously a claim is taken, whether it ultimately settles or not.
Frequently Asked Questions
What is Roundup, and why is it linked to non-Hodgkin lymphoma?
Roundup is a widely used weed killer whose active ingredient, glyphosate, has been the subject of extensive scientific and legal debate. The World Health Organization’s cancer research arm has classified it as a probable human carcinogen, while the EPA maintains it does not pose a cancer risk when used as directed. Lawsuits allege that Monsanto knew or should have known about the cancer risk and failed to adequately warn users.
Am I required to accept the class settlement?
No. If you have a pending Roundup lawsuit, you generally have choices about whether to participate in a class settlement or pursue your claim separately, though the specific options depend on your case’s status. An attorney can walk you through what each path means for your situation.
What if I have a diagnosis but never filed a claim?
You may still be able to pursue a claim, whether through the proposed settlement’s future-claims process or a new individual lawsuit, depending on when you were diagnosed and your state’s filing deadlines. The sooner you speak with an attorney, the more options are likely to remain open.
Is there a deadline to come forward?
Yes, though the specific deadline depends on your state’s statute of limitations and the settlement’s own claims process, both of which vary by state and by claim type. Rather than rely on a generic date, confirm your specific deadline with an attorney as soon as possible.
Talk to a National Roundup Lawsuit Team
You do not have to sort through a $7.25 billion settlement, court deadlines, and medical records on your own. Trial Lawyers United offers a free, confidential consultation to help you understand whether you may qualify and what your options look like. Call 602-560-5170 or contact us online — there is no fee unless we win.
Attorney Advertising. This article is provided for general informational purposes only and does not constitute legal advice. Reading it does not create an attorney-client relationship with Trial Lawyers United LLC. Every case is different, laws vary by state and change over time, and past results do not guarantee or predict a similar outcome in any future matter. Trial Lawyers United LLC maintains its principal office in Phoenix, Arizona; cases in other jurisdictions are handled in association with attorneys licensed in those jurisdictions. If you have a legal question about your specific situation, please consult a licensed attorney.